seattle genetics inc
(SGEN:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - SEATTLE GENETICS INC (SGEN)
2013 revenues at Seattle Genetics Inc. totaled $269.3M USD, while annual losses equaled $0.51 per share.
Quarterly Earnings & Estimates - SEATTLE GENETICS INC (SGEN)
Seattle Genetics Inc.'s Quarterly Earnings
Seattle Genetics Inc. reported 2nd quarter 2014 on 08/2/2014.
Annual Earnings & Estimates - SEATTLE GENETICS INC (SGEN)
Seattle Genetics Inc.'s Annual Earnings
Seattle Genetics Inc. reported annual 2013 losses of $0.51 per share on 02/13/2014.
Quarterly Revenues - SEATTLE GENETICS INC (SGEN)
Annual Revenues - SEATTLE GENETICS INC (SGEN)
Seattle Genetics Inc.'s Annual Revenues
Seattle Genetics Inc. had revenues for the full year 2013 of $269.3M USD. This was 27.7% above the prior year's results.
|ARIAD Pharmaceuticals Inc||$8.13 USD||-0.04|
|Genmab A/S||kr493.00 DKK||-5.80|
|Insys Therapeutics Inc||$60.06 USD||-0.65|
|MorphoSys AG||€74.66 EUR||+0.153|
|Pfizer Ltd/India||1,993 INR||-26.00|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|